CYTEIR THERAPEUTICS INC's ticker is CYT and the CUSIP is 23284P103. A total of 42 filers reported holding CYTEIR THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.7%.
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
OUP Management Co., LLC | 2,459,572 | $6,985,184 | 15.71% |
BML Capital Management, LLC | 3,250,008 | $9,230,023 | 8.48% |
Newtyn Management, LLC | 2,500,444 | $7,101,261 | 1.75% |
VR Advisory Services Ltd | 1,072,968 | $3,047,229 | 1.08% |
Anson Funds Management LP | 1,324,114 | $3,760,484 | 0.76% |
Acuitas Investments, LLC | 329,164 | $934,826 | 0.55% |
Aldebaran Capital, LLC | 143,739 | $408,219 | 0.42% |
Bulldog Investors, LLP | 200,000 | $568,000 | 0.20% |
GABELLI & Co INVESTMENT ADVISERS, INC. | 416,200 | $1,182,008 | 0.19% |
Alta Fundamental Advisers LLC | 117,346 | $333,263 | 0.16% |
Novo Holdings A/S | 676,379 | $1,920,916 | 0.14% |
Vazirani Asset Management LLC | 15,770 | $44,787 | 0.07% |
Marquette Asset Management, LLC | 67,990 | $193,092 | 0.05% |
WITTENBERG INVESTMENT MANAGEMENT, INC. | 28,588 | $81 | 0.03% |
Virtu Financial LLC | 80,428 | $228 | 0.02% |
RBF Capital, LLC | 117,295 | $333,118 | 0.02% |
Pale Fire Capital SE | 57,597 | $163,575 | 0.02% |
CSS LLC/IL | 57,054 | $162,033 | 0.01% |
CANTOR FITZGERALD, L. P. | 132,496 | $376,289 | 0.01% |
GABELLI FUNDS LLC | 442,638 | $1,257,092 | 0.01% |
External links
This page lists CYTEIR THERAPEUTICS INC's shareholders in Q3 2023. To view CYTEIR THERAPEUTICS INC's shareholder history, click here.